Allscripts November 19, 2015 By Is your tech disruptive enough to buck conventional wisdom? Stan Rowe knows a thing or two about shepherding disruptive technologies to market. The Edwards Lifesciences CSO was in on the ground floor with two of medtech's most disruptive treatments, coronary stents and transcatheter aortic valve replacement. Join us Dec. 12 at DeviceTalks West, when Rowe is slated sit down with MassDevice co-founder Brad Perriello for the inside story on how these technologies came to market and what Rowe learned along the way. Register now with the code "TAVR" and save 15% today.